Change and significance of HBcAg-specific Th22 cells in patients with hepatitis B virus infection

Change and significance of HBcAg-specific Th22 cells in patients with hepatitis B virus infection

ObjectiveTo investigate the changes of Th22 cells, interleukin-22 (IL-22), and transcription factor aryl hydrocarbon receptor (AhR) in patients with hepatitis B virus (HBV) infection and their correlation with clinical indices. MethodsA total of 11 patients with acute hepatitis B (AHB) and 38 patien...

Full description

Bibliographic Details
Main Author:	JIN Juan
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Hepatology 2020-11-01
Series:	Linchuang Gandanbing Zazhi
Online Access:	http://www.lcgdbzz.org/qk_content.asp?id=11159

Similar Items

The T cell probiferative response to HBcAg in hepatitis B virus carriers
by: SHEN, CHING-HUNG, et al.
Published: (1992)

Cloning of the Core Antigen (HBcAg) Gene of Hepatitis B Virus into an Eucaryotic Expression Vector
by: Yasemin BULUT, et al.
Published: (2003-06-01)

Association of the expression of HBsAg and HBcAg in liver tissue with antiviral response in children with chronic hepatitis B
by: WANG Limin
Published: (2021-01-01)

Expression of HBcAg in hepatocytes and its association with the efficacy of antiviral therapy
by: FU Xihua
Published: (2021-06-01)

Expression of HBcAg fusion proteins in yeast and an investigation of their immunological properties
by: Beesley, Katrina M.
Published: (1991)

The Effects of HBcAg and HBeAg on the Expression of Cytokine Genes from Murine Macrophages
by: Kung-yen Chang, et al.
Published: (1999)

In vitro expression of precore proteins of hepatitis B virus subgenotype A1 is affected by HBcAg, and can affect HBsAg secretion
by: Aurélie Deroubaix, et al.
Published: (2021-04-01)

Construction and expression of indonesian hepatitis B core antigen (HBcAg) in Lactococcus lactis as potential therapeutic vaccine
by: Rahma Isartina Anwar, et al.
Published: (2019-03-01)

Expression of HBsAg and HBcAg in liver biopsy specimens of chronic B hepatitis patients and its relation with histology activity index
by: Budiana Tanurahardja, et al.
Published: (1996-07-01)

Relationship between HBV DNA and HBeAg in serum and HBcAg and inflammation grade in liver tissue among patients with chronic hepatitis B
by: LIU Xingxiang
Published: (2013-12-01)

Removal of Hepatitis B virus surface HBsAg and core HBcAg antigens using microbial fuel cells producing electricity from human urine
by: Grzegorz Pasternak, et al.
Published: (2019-08-01)

Establishment and functional evaluation of DC-CIK co-culture system with combined loading of HBsAg and HBcAg
by: WANG Shaoyang, et al.
Published: (2017-07-01)

Generation of fusion protein EGFRvIII-HBcAg and its anti-tumor effect in vivo
by: Zhang Ming-xin, et al.
Published: (2009-09-01)

Enhanced stability of a chimeric hepatitis B core antigen virus-like-particle (HBcAg-VLP) by a C-terminal linker-hexahistidine-peptide
by: Jens Schumacher, et al.
Published: (2018-04-01)

CemX Peptide-carrying HBcAg Virus-like Particles Induced Antibodies that Down-regulate mIgE-B lymphocytes
by: 林健仁
Published: (2013)

Adenovirus Vector Harboring the HBcAg and Tripeptidyl Peptidase II Genes Induces Potent Cellular Immune Responses In Vivo
by: Quanhui Tan, et al.
Published: (2017-01-01)

Chimeric HBcAg virus-like particles presenting a HPV 16 E7 epitope significantly suppressed tumor progression through preventive or therapeutic immunization in a TC-1-grafted mouse model
by: Chu X, et al.
Published: (2016-05-01)

Occult Hepatitis B Virus Infection in Egyptian HIV-Infected Patients with Isolated Anti-HBc
by: Naglaa F. Abdelaziz, et al.
Published: (2019-12-01)

Hepatitis B Virus Infection in An Anti-Hbc Negative Patient: a Case Report
by: Ali Talebian, et al.
Published: (2006-07-01)

Hepatitis B Virus Infection and Anti-HBc (Total) Positivity in CKD Patients before Dialysis
by: Fareha Jesmin Rabbi, et al.
Published: (2016-09-01)

Quantitative Anti-HBc in Liver Pathological States in Patients with Chronic Hepatitis B Virus Infection
by: Zhan-qing Zhang, et al.
Published: (2019-01-01)

The prevalence and significance of isolated hepatitis B core antibody (anti-HBc) in endemic population
by: Chul S. Hyun, et al.
Published: (2019-05-01)

Isolated Anti-HBc: Significance and Management
by: Florian MORETTO, et al.
Published: (2020-01-01)

Investigation of occult hepatitis B virus infection in anti-hbc positive patients from a liver clinic.
by: Maria Carmela Martinez, et al.
Published: (2015-01-01)

Prevalence of Anti-HBc Antibodies among HBsAg Negative Individuals and Its Association with Occult Hepatitis B
by: Anitha Madhavan, et al.
Published: (2021-03-01)

Hepatitis B virus screening in contacts of blood donors with antibodies against core protein (anti-HBc), but without surface antigen (HBsAg)
by: Hildenete Monteiro Fortes, et al.
Published: (2006-03-01)

Application of <i>In-Situ</i> and Soft-Sensors for Estimation of Recombinant <i>P. pastoris</i> GS115 Biomass Concentration: A Case Analysis of HBcAg (Mut<sup>+</sup>) and HBsAg (Mut<sup>S</sup>) Production Processes under Varying Conditions
by: Oskars Grigs, et al.
Published: (2021-02-01)

Occult Hepatitis B virus infection among HIV negative and positive isolated anti-HBc individuals in eastern Ethiopia
by: Desalegn Admassu Ayana, et al.
Published: (2020-12-01)

numbers of PFCanti-HBc in patients with chronic Hepatitis
by: Baghdad Science Journal
Published: (2006-03-01)

Clinical characteristics of patients with HBsAg(+) versus HBsAg(-)/HBcAb(+) primary hepatic carcinoma treated by hepatectomy: a comparative analysis
by: YANG Keli
Published: (2015-06-01)

Reactivation risk of Hepatitis B Virus in both HBsAg negative and HBcIgG positive patients with solid malignancy. Is antiviral prophylaxis really necessary?
by: Murat Araz, et al.
Published: (2019-06-01)

Change in HBsAg quantification in the nature history of hepatitis B virus infection and its clinical significance
by: WANG Wei, et al.
Published: (2017-06-01)

Hepatitis B Reactivation in a HBsAg-Negative, HBcAb-Positive Patient Receiving Fludarabine for the Treatment of Chronic Lymphocytic Leukaemia
by: Federica Toscanini, et al.
Published: (2011-01-01)

Hepatitis B Core IgM antibody (anti-HBcIgM) among hepatitis B Surface antigen (HBsAg) negative blood donors in Nigeria
by: Japhet Margaret, et al.
Published: (2011-11-01)

Difluoromethylornithine, a Decarboxylase 1 Inhibitor, Suppresses Hepatitis B Virus Replication by Reducing HBc Protein Levels
by: Binli Mao, et al.
Published: (2020-04-01)

Anti-HBc testing for blood donations in areas with intermediate hepatitis B endemicity
by: Celina Maria Turchi Martelli, et al.
Published: (1999-07-01)

Antibody response to hepatitis B vaccination in isolated anti-HBc positive subjects
by: Hasan Tahsin Gozdas
Published: (2015-01-01)

Changes in hepatitis B virus surface antibody titer and risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients undergoing biologic therapy for rheumatic diseases: a prospective cohort study
by: Ya-Chih Tien, et al.
Published: (2018-11-01)

The Impact of Positive Anti-HBC Marker on Permanent Deferral of Voluntary Blood Donors in Eastern Croatia and Estimation of Occult Hepatitis B Virus Infection Rate
by: Marko Samardžija, et al.
Published: (2020-01-01)

Seroprevalence of HbsAg, anti-HBc and anti-HCV in Southern Brazil, 1999-2001
by: Nilton Rosini, et al.